187 related articles for article (PubMed ID: 2688406)
21. Fluid and solute transfer characteristics in a dialyzer with a high-performance membrane.
Mineshima M
Contrib Nephrol; 2011; 173():103-109. PubMed ID: 21865782
[TBL] [Abstract][Full Text] [Related]
22. Clinical evaluation of a new high-flux cellulose acetate membrane.
Schaefer RM; Huber L; Gilge U; Bausewein K; Vienken J; Heidland A
Int J Artif Organs; 1989 Feb; 12(2):85-90. PubMed ID: 2651325
[TBL] [Abstract][Full Text] [Related]
23. Removal of beta-2-microglobulin by diffusion alone is feasible using highly permeable dialysis membranes.
Naitoh A; Tatsuguchi T; Okada M; Ohmura T; Sakai K
ASAIO Trans; 1988; 34(3):630-4. PubMed ID: 3058183
[TBL] [Abstract][Full Text] [Related]
24. The effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-microglobulin removal from hemodialysis patients.
Petersen J; Moore RM; Kaczmarek RG; Singh B; Yeh I; Hamburger S; Kankam M
Am J Kidney Dis; 1991 Feb; 17(2):174-8. PubMed ID: 1992659
[TBL] [Abstract][Full Text] [Related]
25. Vancomycin elimination during high-flux hemodialysis: kinetic model and comparison of four membranes.
DeSoi CA; Sahm DF; Umans JG
Am J Kidney Dis; 1992 Oct; 20(4):354-60. PubMed ID: 1415203
[TBL] [Abstract][Full Text] [Related]
26. Granulocyte activation during hemodialysis.
Hörl WH; Riegel W; Steinhauer HB; Wanner C; Thaiss F; Bozkurt F; Haag M; Schollmeyer P
Clin Nephrol; 1986; 26 Suppl 1():S30-4. PubMed ID: 3829465
[TBL] [Abstract][Full Text] [Related]
27. Biocompatibility and performance of a modified cellulosic and a synthetic high flux dialyzer. A randomized crossover comparison between cellulose triacetate and polysulphon.
Grooteman MP; Nubé MJ; van Limbeek J; van Houte AJ; Daha MR; van Geelen JA
ASAIO J; 1995; 41(2):215-20. PubMed ID: 7640431
[TBL] [Abstract][Full Text] [Related]
28. Effect of hemodialyzer reuse: dissociation between clearances of small and large solutes.
Leypoldt JK; Cheung AK; Deeter RB
Am J Kidney Dis; 1998 Aug; 32(2):295-301. PubMed ID: 9708616
[TBL] [Abstract][Full Text] [Related]
29. Hollow fiber shape alters solute clearances in high flux hemodialyzers.
Leypoldt JK; Cheung AK; Chirananthavat T; Gilson JF; Kamerath CD; Deeter RB
ASAIO J; 2003; 49(1):81-7. PubMed ID: 12558312
[TBL] [Abstract][Full Text] [Related]
30. Biocompatibility aspects of cellophane, cellulose acetate, polyacrylonitrile, polysulfone and polycarbonate hemodialyzers.
Smeby LC; Widerøe TE; Balstad T; Jørstad S
Blood Purif; 1986; 4(1-3):93-101. PubMed ID: 3730167
[TBL] [Abstract][Full Text] [Related]
31. Beta-2-microglobulin handling in dialysis.
Klinke B; Röckel A; Perschel W; Abdelhamid S; Fiegel P; Walb D
Contrib Nephrol; 1989; 74():139-46. PubMed ID: 2702131
[No Abstract] [Full Text] [Related]
32. Beta 2-microglobulin removal by synthetic dialysis membranes. Mechanisms and kinetics of the molecule.
Ronco C; Heifetz A; Fox K; Curtin C; Brendolan A; Gastaldon F; Crepaldi C; Fortunato A; Pietribasi G; Caberlotto A; Brunello A; Milan Manani S; Zanella M; La Greca G
Int J Artif Organs; 1997 Mar; 20(3):136-43. PubMed ID: 9151148
[TBL] [Abstract][Full Text] [Related]
33. Dialyzer permeability for low-molecular-weight proteins. Comparison between polysulfone, polyamide and cuprammonium-rayon dialyzers.
Nensel U; Röckel A; Hillenbrand T; Bartel J
Blood Purif; 1994; 12(2):128-34. PubMed ID: 7530014
[TBL] [Abstract][Full Text] [Related]
34. Dialyzer performance in the clinic: comparison of six low-flux membranes.
Kerr PG; Lo A; Chin Mm; Atkins RC
Artif Organs; 1999 Sep; 23(9):817-21. PubMed ID: 10491028
[TBL] [Abstract][Full Text] [Related]
35. Effect of hemodialysis membrane type on parathyroid hormone removal.
Kudlac H; Fielding AM; Williams AJ
Miner Electrolyte Metab; 1994; 20(5):245-9. PubMed ID: 7700210
[TBL] [Abstract][Full Text] [Related]
36. In vivo solute extraction by a new polysulphone membrane with low ultrafiltration capacity.
Vanholder R; Krause A; De Smet R; Ringoir S
ASAIO Trans; 1988; 34(3):598-601. PubMed ID: 3196570
[TBL] [Abstract][Full Text] [Related]
37. Synthetically modified cellulose: an alternative to synthetic membranes for use in haemodialysis?
Hoenich NA; Woffindin C; Stamp S; Roberts SJ; Turnbull J
Biomaterials; 1997 Oct; 18(19):1299-303. PubMed ID: 9307219
[TBL] [Abstract][Full Text] [Related]
38. Interleukin 8 and biocompatibility of dialysis membranes.
Niwa T; Miyazaki T; Sato M; Kambe F; Tsuzuki T; Uema K; Maeda K; Seo H
Am J Nephrol; 1995; 15(3):181-5. PubMed ID: 7618641
[TBL] [Abstract][Full Text] [Related]
39. The effect of dialysis membrane on serum beta 2-microglobulin (beta 2M) in chronic haemodialysis patients.
Farrell J; Bastani B
Nephrol Dial Transplant; 1997 Apr; 12(4):856. PubMed ID: 9141041
[No Abstract] [Full Text] [Related]
40. β-trace protein is highly removed during haemodialysis with high-flux and super high-flux membranes.
Donadio C; Tognotti D; Caponi L; Paolicchi A
BMC Nephrol; 2017 Feb; 18(1):68. PubMed ID: 28219328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
